Matos L, Vilela R, C outinho MF, Gaspar P, Alves S. Development of an antisense-mediated exon skipping approach as a therapeutic option for the ML II-causing mutation c.3503_35044delTC . 21st Annual Meeting SPGH. Oral Communication. November, 2017. Almada, Portugal.